Protocols

Cambrex completes $24M API manufacturing facility; Twist and LakePharma partner on antibody contract work

Cambrex Corporation $CBM completed its $24 million API (HPAPI) manufacturing facility at its site in Charles City, IA. The facility is undergoing validation and is expected to be ready to start customer projects in May.

PDL BioPharma is investing up to $60 million into Evofem Biosciences. PDL is investing alongside two existing Evofem shareholders, which have the right to invest up to $10 million each. The money will be used to back their pre-commercial activities for Amphora, its contraceptive gel for women.

Twist Bioscience and LakePharma announced a strategic collaboration to offer antibody discovery and development solutions to pharmaceutical and biotechnology customers.


The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 47,300+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Research Scientist - Immunology
Recursion Pharmaceuticals Salt Lake City, UT
Director of Operations
Atlas Venture Cambridge, MA

Visit Endpoints Careers ->